We envision a world without a risk for renal toxicity for compounds entering clinical stages of drug development.
Cell4Pharma aims to reduce the failure rate in late clinical stages due to renal tox below 3% market wide within the next 10 years. Without the use of animal experimentation.
This ambition is supported by our human renal cell line ciPTEC validated during extensive collaborations with the pharmaceutical industry. More than 10 years of research lead to the development of robust cell-based assays focusing on the detection of highly specific biomarkers for renal toxicity.
Company Details
- Employees
- 7
- Address
- Kloosterstraat 9, Oss Pivot Park,netherlands
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- cell4pharma.com
- Keywords
- delivery to CROs.
- HQ
- Oss, North Brabant
Cell4pharma Questions
Cell4Pharma's website is cell4pharma.com
Cell4Pharma's LinkedIn profile is https://nl.linkedin.com/company/cell4pharma
Cell4Pharma has
7 employees.
View email and phone details for 7
employees at Cell4Pharma.
Cell4Pharma's industry is
Biotechnology Research
Cell4Pharma's top competitors are
Ipa (Immunoprecise Antibodies),
Citryll,
Ribopro,
Bioconnection,
Oncolines B.v.,
Mercurna,
Innatoss Laboratories,
Byondis,
Pivot Park,
Accellerate.
Cell4Pharma's categories are Biotechnology Research
